Reckitt Benckiser affirms full-year targets

LONDON (Reuters) - Reckitt Benckiser reported slightly better than expected quarterly sales on Monday and affirmed its full-year forecast after a severe flu season boosted sales of medicines and other health products. The British maker of Mucinex cold medicine, Dettol soaps and Durex condoms said that like-for-like sales rose 5 percent in the first quarter. Analysts on average were expecting an increase of 4.9 percent. The company said it is still on track for full-year growth of 4 percent to 5 percent and for its operating margin to expand at a "moderate" rate in the medium term. (Reporting by Martinne Geller in London; Editing by David Goodman)